Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
Journal Article
|Research
2011-11-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2011-11-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND
Drug resistance poses a significant challenge for the successful application of highly active antiretroviral therapy (HAART) globally. Furthermore, emergence of HIV-1 isol...
Drug resistance poses a significant challenge for the successful application of highly active antiretroviral therapy (HAART) globally. Furthermore, emergence of HIV-1 isol...
Journal Article
|Research
2021-09-01 • International Journal of Tuberculosis and Lung Disease
2021-09-01 • International Journal of Tuberculosis and Lung Disease
The wider availability of dolutegravir (DTG) containing HIV therapy for patients living with multidrug-resistant TB (MDR-TB) presents several advantages. DTG-based antiretroviral therapy...
Journal Article
|Research
2014-06-01 • International Journal of Tuberculosis and Lung Disease
2014-06-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
The optimal treatment for tuberculosis (TB) in human immunodeficiency virus (HIV) infected patients in resource-poor settings receiving lopinavir-ritonavir (LPV/r) based ...
The optimal treatment for tuberculosis (TB) in human immunodeficiency virus (HIV) infected patients in resource-poor settings receiving lopinavir-ritonavir (LPV/r) based ...
Journal Article
|Research
2017-03-19 • EBioMedicine
2017-03-19 • EBioMedicine
Tenofovir disoproxil fumarate (TDF) genotypic resistance defined by K65R/N and/or K70E/Q/G occurs in 20% to 60% of individuals with virological failure (VF) on a WHO-recommended TDF-cont...
Journal Article
|Research
2009-02-01 • Journal of Tropical Pediatrics
2009-02-01 • Journal of Tropical Pediatrics
The treatment of concurrent HIV and tuberculosis (TB) in children <3 years of age has not been well-studied and is complicated by potential drug-drug interactions. The recommended antire...
Journal Article
|Research
2012-09-28 • PLOS One
2012-09-28 • PLOS One
In HIV-infected patients receiving rifampicin-based treatment for tuberculosis (TB), the dosage of lopinavir/ritonavir (LPV/r) is adjusted to prevent sub-therapeutic lopinavir concentrat...
Journal Article
|Research
2010-07-01 • International Journal of Tuberculosis and Lung Disease
2010-07-01 • International Journal of Tuberculosis and Lung Disease
OBJECTIVES
A prospective cohort study was conducted among human immunodeficiency virus (HIV) infected in-patients with tuberculosis (TB) or other opportunistic infections (OIs) in So...
A prospective cohort study was conducted among human immunodeficiency virus (HIV) infected in-patients with tuberculosis (TB) or other opportunistic infections (OIs) in So...
Journal Article
|Research
2013-12-09 • AIDS Patient Care and STDs
2013-12-09 • AIDS Patient Care and STDs
Abstract We sought to develop individual-level Early Warning Indicators (EWI) of virologic failure (VF) for clinicians to use during routine care complementing WHO population-level EWI. ...